regulatory
confidence high
sentiment negative
materiality 0.65
KALA BIO receives Nasdaq bid price deficiency notice; 180-day compliance period until July 20, 2026
KALA BIO, Inc.
- Letter dated Jan 20, 2026; closing bid price below $1.00 for 30 consecutive business days (Dec 3, 2025–Jan 16, 2026).
- Must maintain closing bid price ≥$1.00 for at least ten consecutive business days during the compliance period to regain compliance.
- If not cured by July 20, 2026, may be eligible for an additional 180-day period if other Nasdaq listing standards are met.
- No immediate impact on stock listing; shares continue trading on Nasdaq subject to other requirements.